120 related articles for article (PubMed ID: 12038453)
41. Prevalence and clinical significance of anticardiolipin, anti-beta2-glycoprotein-1, and anti-heat shock protein-70 autoantibodies in sudden sensorineural hearing loss.
Gross M; Eliashar R; Ben-Yaakov A; Ulmansky R; Elidan J
Audiol Neurootol; 2008; 13(4):231-8. PubMed ID: 18259075
[TBL] [Abstract][Full Text] [Related]
42. [Antibodies to beta2-glycoprotein I in systemic lupus erythematosus: new laboratory marker of antiphospholipid syndrome].
Reshetniak TM; Derksen RV; Alekberova ZS; Horbach D; De Groot F; Nasonov EL; Kalashnikova LA; Match ES; Nasonova VA
Klin Med (Mosk); 1998; 76(3):36-40. PubMed ID: 9575746
[TBL] [Abstract][Full Text] [Related]
43. Accuracy of the first fully automated method for anti-cardiolipin and anti-beta2 glycoprotein I antibody detection for the diagnosis of antiphospholipid syndrome.
Villalta D; Alessio MG; Tampoia M; Da Re A; Stella S; Da Re M; Tozzoli R; Bizzaro N
Ann N Y Acad Sci; 2009 Sep; 1173():21-7. PubMed ID: 19758127
[TBL] [Abstract][Full Text] [Related]
44. Acquired activated protein C resistance associated with IgG antibodies against beta2-glycoprotein I and prothrombin as a strong risk factor for venous thromboembolism.
Nojima J; Kuratsune H; Suehisa E; Iwatani Y; Kanakura Y
Clin Chem; 2005 Mar; 51(3):545-52. PubMed ID: 15637132
[TBL] [Abstract][Full Text] [Related]
45. [Comparative study of the occurrence of beta-2-glycoprotein I antibodies (anti-beta-2-GPI) and anticardiolipin antibodies (ACA) in the blood of pregnant women].
Fialová L; Mikulíková L; Malbohan I; Benesová O; Zwinger A
Ceska Gynekol; 1999 Jul; 64(4):255-61. PubMed ID: 10568065
[TBL] [Abstract][Full Text] [Related]
46. Anti-beta2-glycoprotein I and anti-prothrombin antibodies in antiphospholipid-negative patients with thrombosis: a case control study.
Previtali S; Barbui T; Galli M
Thromb Haemost; 2002 Nov; 88(5):729-32. PubMed ID: 12428085
[TBL] [Abstract][Full Text] [Related]
47. Prevalence of hepatitis C virus infection in patients with antiphospholipid syndrome.
Muñoz-Rodríguez FJ; Tàssies D; Font J; Reverter JC; Cervera R; Sánchez-Tapias JM; Mazzara R; Ordinas A; Ingelmo M
J Hepatol; 1999 May; 30(5):770-3. PubMed ID: 10365800
[TBL] [Abstract][Full Text] [Related]
48. [Clinical and immunological relevance of antiphospholipid antibodies in patients with lymphoma].
Zhou YS; Ying ZT; Li R; Zhu J; Li ZG
Zhonghua Yi Xue Za Zhi; 2011 Oct; 91(37):2607-10. PubMed ID: 22321923
[TBL] [Abstract][Full Text] [Related]
49. Antiphospholipid antibody tests: spreading the net.
Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
[TBL] [Abstract][Full Text] [Related]
50. Significance of valine/leucine247 polymorphism of beta2-glycoprotein I in antiphospholipid syndrome: increased reactivity of anti-beta2-glycoprotein I autoantibodies to the valine247 beta2-glycoprotein I variant.
Yasuda S; Atsumi T; Matsuura E; Kaihara K; Yamamoto D; Ichikawa K; Koike T
Arthritis Rheum; 2005 Jan; 52(1):212-8. PubMed ID: 15641049
[TBL] [Abstract][Full Text] [Related]
51. Arteriosclerosis obliterans associated with anti-cardiolipin antibody/beta2-glycoprotein I antibodies as a strong risk factor for ischaemic heart disease in patients with systemic lupus erythematosus.
Nojima J; Masuda Y; Iwatani Y; Kuratsune H; Watanabe Y; Suehisa E; Takano T; Hidaka Y; Kanakura Y
Rheumatology (Oxford); 2008 May; 47(5):684-9. PubMed ID: 18375400
[TBL] [Abstract][Full Text] [Related]
52. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
Sahin M; Duzgun N; Tunc SE; Tutkak H
Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
[TBL] [Abstract][Full Text] [Related]
53. Anti-cardiolipin and anti-beta2-glycoprotein I antibodies in patients with inflammatory bowel disease.
Koutroubakis IE; Petinaki E; Anagnostopoulou E; Kritikos H; Mouzas IA; Kouroumalis EA; Manousos ON
Dig Dis Sci; 1998 Nov; 43(11):2507-12. PubMed ID: 9824143
[TBL] [Abstract][Full Text] [Related]
54. [Antiphospholipid antibodies: their prevalence, clinical significance and correlation with cytokine levels in acute myeloid leukemia and non-Hodgkin's lymphoma].
Sciarra A; Stasi R; Stipa E; Masi M; Oliva F; Olivieri M; Perrotti A; Zaccari G; Amadori S; Papa G
Recenti Prog Med; 1995 Feb; 86(2):57-62. PubMed ID: 7754173
[TBL] [Abstract][Full Text] [Related]
55. [Antiphospholipid syndrome and stroke].
Kitagawa Y
Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
[TBL] [Abstract][Full Text] [Related]
56. Study of anti-cardiolipin and anti-beta2-glycoprotein I antibodies in patients with ischemic stroke.
Cojocaru IM; Cojocaru M; Muşuroi C; Botezat M
Rom J Intern Med; 2003; 41(2):189-204. PubMed ID: 15526503
[TBL] [Abstract][Full Text] [Related]
57. [Antibodies to beta2-glycoprotein-1 in patients with systemic lupus erythematosus].
Borodin AG; Baranov NG; Nasonov EL
Klin Med (Mosk); 2001; 79(2):49-51. PubMed ID: 11419087
[TBL] [Abstract][Full Text] [Related]
58. Anticardiolipin and anti-beta2-glycoprotein-I antibodies in hypertensive disorders of pregnancy.
Valdés-Macho E; Cabiedes J; Villa AR; Cabral AR; Alarcón-Segovia D
Arch Med Res; 2002; 33(5):460-5. PubMed ID: 12459316
[TBL] [Abstract][Full Text] [Related]
59. Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus.
Alessandri C; Bombardieri M; Di Prospero L; Conigliaro P; Conti F; Labbadia G; Misasi R; Sorice M; Valesini G
Clin Exp Immunol; 2005 Apr; 140(1):173-80. PubMed ID: 15762889
[TBL] [Abstract][Full Text] [Related]
60. Anti-beta2-glycoprotein I in childhood immune thrombocytopenic purpura.
El-Bostany EA; El-Ghoroury EA; El-Ghafar EA
Blood Coagul Fibrinolysis; 2008 Jan; 19(1):26-31. PubMed ID: 18180612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
